Molecular Targets and Targeted Therapies for Malignant Mesothelioma

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|9|855-867

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.9, 2008-04, pp. : 855-867

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Targets in Malignant Pleural Mesothelioma Treatment

By  

Current Drug Targets, Vol. 10, Iss. 12, 2009-12 ,pp. : 1235-1244

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapies for malignant pleural mesothelioma

By Ceresoli Giovanni Luca   Zucali Paolo Andrea  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 833-844

Informa Healthcare

Access to resources Recommend Favorite

Therapies currently in Phase II trials for malignant pleural mesothelioma

By Pinton Giulia   Manente Arcangela Gabriella   Tavian Daniela   Moro Laura   Mutti Luciano  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1255-1263

Informa Healthcare

Access to resources Recommend Favorite

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 19-26

Bentham Science Publishers

Access to resources Recommend Favorite

ROS1 Kinase Inhibitors for Molecular-Targeted Therapies

By  

Current Medicinal Chemistry, Vol. 23, Iss. 2, 2016-01 ,pp. : 142-160

Bentham Science Publishers

Access to resources Recommend Favorite